References
- Dreikorn K., Richter R. Conservative nonhormonal treatment of patients with benign prostatic hyperplasia. New Developments in Biosciences 5, Prostatic Hyperplasia, R. Ackerman, F. H. Schroeder. Walter de Gruyter & CO., Brlin, New York 1989; 109–131
- Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995; 273: 607–9
- Dreikorn K., Borkowski A., Braeckman J., et al. Other Medical Therapies. Proceedings of the Fourth International Consultation on Benign Prostatic Hyperplasia (BPH). Scientific Communication International Limited, Paris 1997
- Lowe F. C., Ku J. C. Phytotherapy in treatment of benign prostatic hyperplasia: A critical review. Urology 1996; 48: 12
- Champault G., Patel J. C., Bonnard A. M. A double blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br. J. Clin. Pharmacol. 1984; 18: 461–2
- Gerber G. S. Saw palmetto for the treatment of men with lower urinary tract symptoms. J. Urol. 2000; 163: 1408–1412
- Gerber G. S., Zagaja G. P., Bales G. T., et al. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: Effects on urodynamic parameters and voiding symptoms. Urology 1998; 51: 1003–7
- Crimi A., Russo A. Extract of Serenoa repens for the treatment of the functional disturbances of prostatic hypertrophy. Med. Praxis. 1983; 4: 47–51
- Descotes J. L., Rambeuad J. J., Deschaseaux P., et al. Placebo-controlled evaluation of the efficacy and tolerability of Permixone in benign prostatic hyperplasia after exclusion of placebo responders. Clin. Drug Invest. 1995; 9: 291–7
- Carraro J. C., Raynard J. P., Koch G., et al. Comparison of phytotherapy (Permixone) with finasteride in the treatment of benign prostatic hyperplasia: A randomised international study of 1098 patients. Prostate 1996; 29: 231–40
- Dreikorn K., Borkowski A., Braeckman J., (1998) Other medical therapies. Proceedings of the Fourth International Consultation on Benign Prostatic Hyperplasia (BPH). 1997, L. Denis, K. Griffiths, G. Murphy, et al. Plymbridge Distributors, Plymouth, 633–659
- Wagner H., Flachsbarth H., Vogel G. A new antiprostatic principle of stinging nettle (Urtica dioica) roots. Phytomedicine 1994; 213–224
- Hirano T., Homma M., Oka K. Effects of stinging nettle root extracts and their steroid components on the Na+, K+-ATPase of the benign prostatic hyperplasia. Planta Med. 1994; 60: 30–33
- Hryb D. J., Khan M. S., Romas N. A., Rosner W. The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes. Planta Med. 1995; 61: 31–2
- Kirby R. S., Christmas T. J. Benign Prostatic Hyperplasia. Mosby-Yearbook Europe Ltd., Hong Kong 1994
- Engelmann U., Boss G., Kres H. Thrapie der beningnen prostathyperplasite mit Bazoton Liquidum. Urologe B. 1996; 36: 287–291
- Ahmed H. H., Fayez M., Diab A., El-Badry A. A. Effect of beta-sitosterol alone and in combination with naloxone or L-dopa on serum prolactin, luteinizing hormone and follicle stimulating hormone of female ovariectomised rate. J. Egypt Vet. Med. Ass. 1987; 47: 453–60